RAS Function in cancer cells: translating membrane biology and biochemistry into new therapeutics.

ABSTRACT: The three human RAS proteins are mutated and constitutively activated in ∼20% of cancers leading to cell growth and proliferation. For the past three decades, many attempts have been made to inhibit these proteins with little success. Recently; however, multiple methods have emerged to inhibit KRAS, the most prevalently mutated isoform. These methods and the underlying biology will be discussed in this review with a special focus on KRAS-plasma membrane interactions.

SUBMITTER: Kattan WE 

PROVIDER: S-EPMC7891675 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature